Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
IM Cannabis Corp
(CSE:
IMCC
)
2.650
-0.050 (-1.85%)
Streaming Delayed Price
Updated: 12:11 PM EST, Nov 7, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about IM Cannabis Corp
< Previous
1
2
Next >
Canopy Growth And Other Top Cannabis Companies To Report Earnings: Will Results Get Pot Stocks On Track Following Post-Election Dip?
November 06, 2024
Canopy Growth Corporation (TSX: WEED) (NASDAQ: CGC) will report the second quarter of fiscal year 2025 ended Sept. 30, before financial markets open on Friday, Nov. 8, 2024. IM Cannabis Corp. (CSE:...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
The Ever-Evolving Cannabis Industry: These Are Latest Leadership Changes You Should Know About
October 10, 2024
The U.S. Hemp Roundtable made headlines in early September as its board of directors welcomed two distinguished leaders from the hemp beverage sector to its officer ranks. New York's chief equity...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis' $1.6M Non-Brokered Private Placement Offering, Here's What Investors Need To Know
October 04, 2024
Medical cannabis company with operations in Israel and Germany, IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC), intends to undertake a non-brokered private placement offering of up to $1,613,000 through...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
How Cannabis Legalization In Germany Boosted This Company's Revenue, Will Spain's Medical Marijuana Framework Do The Same?
October 02, 2024
Spain's Ministry of Health revealed this week a draft royal decree for public consultation, outlining the suggested regulations for prescribing cannabis-based medications, reported Business of...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Soars: German Sales Surge 200% In First 3 Months Post-Legalization, Q2 Revenue Up 12% YoY
August 14, 2024
The company, announced its financial results Wednesday for the second quarter ended June 30, 2024, revealing a 12% year-over-year increase in revenue to CA$14.8 million in the second quarter of 2023....
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now
August 06, 2024
Medical cannabis company IM Cannabis Corp. (CSE: IMCC) (NASDAQ: IMCC), with operations in Israel and Germany, will report operational and financial results for the second quarter of 2024 ended June 30,...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Announces Major Share Consolidation Plan: What Investors Need To Know
July 05, 2024
IM Cannabis announces a share consolidation effective July 12, aiming to enhance marketability and streamline shares.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Global Weed Business: Flora Buys Australian Vaporizers As IM Cannabis Doubles Down On Germany
June 05, 2024
Lifeist Wellness Inc. (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF) said on Wednesday the sale of Australian Vaporizers Pty Ltd., its wholly owned Australian subsidiary to Flora Growth Corp. (NASDAQ:...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Doubles Down On Germany Following Legalization Policy Change, Reports YoY Drop In Q1 Gross Profit And Revenue
May 08, 2024
IM Cannabis reported a 13% sequential increase in revenue for the three months ended March 31, 2024, hitting CA$10.7 million ($7.8 million). That is, however, a 4% decrease compared to the same quarter...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Avant Brands Bolsters International Growth in German Cannabis Market Through Partnership with IMC
April 04, 2024
Via
ACCESSWIRE
IM Cannabis' Q4 Revenue: Gross Profit Drops Due To Negative Impact Of Israel-Hamas War, Sees Germany As Growth Opportunity
March 28, 2024
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) announced on Thursday its financial and operational results for the year ended Dec. 2023. The Toronto-headquartered medical cannabis company with a focus on...
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Stock Drops On Q2 Earnings, CEO Touts Strategic Decisions That Led To 'Sustainable Profitability'
August 14, 2023
IM Cannabis Corp. (NASDAQ: IMCC) (CSE: IMCC) reported its second-quarter financial results on Tuesday for the period ending June 30, 2023.
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Avant Brands and IM Cannabis Announce the Launch of BLK MKT in Israel
October 12, 2022
Via
ACCESSWIRE
IM Cannabis announces Focus Medical's Import of 400 Kilograms of Premium-Indoor-Grown Dried Cannabis from Canada to Israel
January 19, 2022
The successful import demonstrates the strength of the IM Cannabis global supply chain and business model TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / January 19, 2022 / IM Cannabis Corp. (the...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Economy
Exposures
Cannabis
Supply Chain
IM Cannabis Corp. Appoints Rinat Efrima as New Chief Executive Officer of IMC Holdings, the Company’s Israeli Subsidiary
January 13, 2022
Oren Shuster remains Chief Executive Officer and Director of IM Cannabis Corp.; other managerial changes include the promotion of Yael Harrosh to Chief Legal and Operations Officer of IM Cannabis Corp....
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
IM Cannabis to Launch WAGNERS Brand in Germany
December 07, 2021
IM Cannabis expects to export premium, indoor-grown Canadian cannabis in 2022 to the rapidly evolving German medical cannabis market TORONTO, ON, GLIL YAM, ISRAEL and BAD OLDESLOE, GERMANY / ACCESSWIRE...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
IM Cannabis To Buy Jerusalem-Based Medical Marijuana Pharmacy For $4.9M In Cash And Stock
December 01, 2021
IM Cannabis Corp. (CSE:IMCC), (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis to Acquire Oranim, Jerusalem's Leading Medical Cannabis Pharmacy
December 01, 2021
Transaction positions IM Cannabis as one of the largest retailers of medical cannabis in Israel; Retail segment combined annualized revenue of approximately $44 million Oranim's trailing 12-month...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
IM Cannabis To Debut WAGNERS Brand In Israel After Receiving Regulatory Approval
November 30, 2021
IM Cannabis Corp. (CSE:IMCC) (NASDAQ:
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
IM Cannabis Announces Focus Medical's Receipt of Israeli Ministry of Health Import Permit; Plans to Launch WAGNERS Brand in Israel
November 29, 2021
IM Cannabis' popular recreational cannabis brand WAGNERS will be available in Israel in 2022, enhancing IM Cannabis' presence in the market TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 29,...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Exposures
COVID-19
Cannabis
IM Cannabis Announces Fourth Installment of Shares in Connection with the Panaxia Transaction
November 18, 2021
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / November 18, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC)(NASDAQ:IMCC), a leading medical and adult-use recreational cannabis...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Law Enforcement
Exposures
COVID-19
Cannabis
Legal
IM Cannabis Announces Third Quarter 2021 Financial Results and Provides Outlook and Business Update
November 15, 2021
Q3 2021 revenues of $14.4 million; a 30% increase from Q2 2021 Gross margin improved to 20% from 5.4% in Q2 2021; expected to increase further in Q4 and into 2022 Canadian recreational brands WAGNERS...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Law Enforcement
Exposures
COVID-19
Cannabis
Legal
IMC Announces Third Installment of Shares in Connection with the Panaxia Transaction
October 20, 2021
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / October 20, 2021 / IM Cannabis Corp. (the "Company" or "IM Cannabis") (CSE:IMCC, NASDAQ:IMCC), a leading medical and adult-use recreational cannabis...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Law Enforcement
Exposures
COVID-19
Cannabis
Legal
IMC Provides Further Details on Panaxia Transaction
September 08, 2021
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / September 8, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Law Enforcement
Exposures
COVID-19
Cannabis
Intellectual Property
IM Cannabis Announces Q2 2021 Financial Results and Signing of Definitive Agreement to Acquire Vironna Pharm, Accelerating its Vertical Integration Strategy in Israel
August 16, 2021
Q2 2021 revenues of $11.1 million, a 27% increase from Q1 2021 Acquisition of Vironna pharmacy positions IMC in rapidly growing Arab consumer segment in Israel Following strong start to Q3 across each...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Law Enforcement
Exposures
COVID-19
Cannabis
Intellectual Property
IMC Partners with Leading US Brand to Launch cbdMD Products in Israel and Provides Further Details on Panaxia Transaction
August 09, 2021
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 9, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC, NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Law Enforcement
Exposures
COVID-19
Cannabis
Legal
IMC Announces Results of its Annual General and Special Meeting of Shareholders
August 03, 2021
TORONTO, ON and GLIL YAM, ISRAEL / ACCESSWIRE / August 3, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC), (NASDAQ:IMCC), a multi-country operator ("MCO") in the medical and adult-use...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Exposures
Cannabis
IMC Accelerates its Israeli Retail Position through Acquisition of Leading Retailer and Distributor Pharm Yarok and Rosen High Way
July 28, 2021
- Strategically located, best in class retailer with approximately CAD$8 million in annualized revenue - Purchase price of CAD$4.6 million TORONTO, ON, GLIL YAM and NATANYA, ISRAEL / ACCESSWIRE / July...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Intellectual Property
Law Enforcement
Exposures
COVID-19
Cannabis
Intellectual Property
IM Cannabis Provides Update on German Operations and Financial Outlook
July 23, 2021
TORONTO, ON, BAD OLDESLOE, GERMANY, and GLIL YAM, ISRAEL / ACCESSWIRE / July 23, 2021 / IM Cannabis Corp. ("IMC" or the "Company") (CSE:IMCC) (NASDAQ:IMCC), a multi-country operator ("MCO") in the...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Law Enforcement
Exposures
COVID-19
Cannabis
Legal
IM Cannabis Provides Business, Legal and Regulatory Update
July 13, 2021
- IMC subsidiary, Adjupharm, to expand German product portfolio with unique strains via supply agreements with The Green Organic Dutchman and Natural MedCo - German Brand Institute awards IMC with the...
From
IM Cannabis Corp.
Via
AccessWire
Topics
Cannabis
Law Enforcement
Exposures
COVID-19
Cannabis
Legal
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.